<?xml version="1.0" encoding="UTF-8"?>
<p>The therapeutic effects of medicines applied for the treatment of rheumatoid arthritis [
 <xref rid="B31-molecules-25-02944" ref-type="bibr">31</xref>] along with those of some other drugs such as antiretroviral drugs (darunavir, lopinavir in combination with ritonavir) [
 <xref rid="B32-molecules-25-02944" ref-type="bibr">32</xref>] on SARS-CoV-2 have generated interest in identifying similar mechanisms of viral infection shared by SARS-CoV-2 and HIV-1, in particular their effects on the hostâ€™s organism. Another important fact is that SARS-CoV-2 can cause serious complications in people with comorbidities [
 <xref rid="B11-molecules-25-02944" ref-type="bibr">11</xref>,
 <xref rid="B33-molecules-25-02944" ref-type="bibr">33</xref>,
 <xref rid="B34-molecules-25-02944" ref-type="bibr">34</xref>,
 <xref rid="B35-molecules-25-02944" ref-type="bibr">35</xref>], in particular, by causing the so-called cytokine release syndrome [
 <xref rid="B33-molecules-25-02944" ref-type="bibr">33</xref>].
</p>
